tiprankstipranks
Trending News
More News >
MedCap AB (DE:61MA)
:61MA
Germany Market

MedCap AB (61MA) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Buy
12Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
MedCap AB’s (61MA) Moving Averages Convergence Divergence (MACD) indicator is 1.83, suggesting MedCap AB is a Sell.
MedCap AB’s (61MA) 20-Day exponential moving average is 36.73, while MedCap AB’s (61MA) share price is €40.55, making it a Buy.
MedCap AB’s (61MA) 50-Day exponential moving average is 35.72, while MedCap AB’s (61MA) share price is €40.55, making it a Buy.

MedCap AB (61MA) Pivot Points

May 13, 2025, 04:03 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
38.92
39.13
39.57
39.78
40.22
40.43
40.87
Fibonacci
39.13
39.38
39.54
39.78
40.03
40.19
40.43
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MedCap AB (61MA) Moving Averages

May 13, 2025, 04:03 PM
Period
Simple
Exponential
MA5
39.73Buy
39.49Buy
MA10
38.44Buy
38.40Buy
MA20
35.81Buy
36.73Buy
MA50
34.10Buy
35.72Buy
MA100
38.25Buy
37.51Buy
MA200
42.03Sell
40.75Sell
MedCap AB’s (61MA) 10-Day exponential moving average is 38.40, while MedCap AB’s (61MA) share price is €40.55, making it a Buy.
MedCap AB’s (61MA) 100-Day exponential moving average is 37.51, while MedCap AB’s (61MA) share price is €40.55, making it a Buy.
MedCap AB’s (61MA) stock price is €40.55 and MedCap AB’s (61MA) 50-day simple moving average is 34.10, creating a Buy signal.
MedCap AB’s (61MA) stock price is €40.55 and MedCap AB’s (61MA) 100-day simple moving average is 38.25, creating a Buy signal.
MedCap AB’s (61MA) stock price is €40.55 and MedCap AB’s (61MA) 200-day simple moving average is 42.03, creating a Sell signal.

MedCap AB (61MA) Technical Indicators

May 13, 2025, 04:03 PM
Name
Value
Implied Action
RSI (14)
72.47
Sell
STOCH (9,6)
82.97
Sell
STOCHRSI (14)
90.15
Sell
MACD (12,26)
1.83
Sell
ADX (14)
31.87
Neutral
Williams %R
-8.82
Sell
CCI (14)
108.87
Sell
ATR (14)
0.78
-
Ultimate Oscillator
66.88
Neutral
ROC
16.45
Buy
MedCap AB’s (61MA) Relative Strength Index (RSI) is 72.47, creating a Sell signal.
MedCap AB’s (61MA) Trend Strength Indicator (ADX) is 31.87, creating a Neutral signal.
MedCap AB’s (61MA) Commodity Channel Index (CCI) is 108.87, creating a Sell signal.
MedCap AB’s (61MA) Price Rate of Change (ROC) is 16.45, creating a Buy signal.

FAQ

Is 61MA a Buy, Hold, or Sell?
Based on 61MA’s technical indicators, 61MA is a Buy.
    What is 61MA’s RSI (14)?
    61MA’s RSI (14) is 72.47, which suggests 61MA is a Sell.
      What is 61MA’s MACD?
      61MA’s MACD is 1.83, which suggests 61MA is a Sell.
        What is 61MA’s 5-day moving average?
        61MA’s 5-day moving average is 39.73, which suggests 61MA is a Buy.
          What is 61MA’s 20-day moving average?
          61MA 20-day moving average is 35.81, which suggests 61MA is a Buy.
            What is 61MA’s 50-day moving average?
            61MA’s 50-day moving average is 34.10, which suggests 61MA is a Buy.
              What is 61MA’s 200-day moving average?
              61MA’s 200-day moving average is 42.03, which suggests 61MA is a Sell.
                What is 61MA’s Williams % R (14)?
                61MA’s Williams % R (14) is -8.82, which suggests 61MA is a Sell.
                  What is 61MA’s CCI (14)?
                  61MA’s CCI (14) is 108.87, which suggests 61MA is a Sell.
                    What is the share price of MedCap AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis